Comparing cotinine and NNAL verification of self-reported smoking status among lung cancer screening eligible population from the 2007-2014 National Health and Nutrition Examination Survey (NHANES).

Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
Weixin Li, Bian Liu

Abstract

Background: Biochemical verification of self-reported smoking status is not common among the population eligible for lung cancer screening (LCS). Methods: We used urinary NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides) and serum cotinine as the gold standard to determine the validity and reliability of self-reported smoking status from the 2007-2014 National Health and Nutrition Examination Survey (NHANES). Results: We found 2.3% (n = 652, equivalent to 5.3 million weighted population) of adults eligible for LCS according to the current United States Preventive Services Task Force guideline. Self-reported current smoking status performed similarly against NNAL and cotinine: sensitivity [89.7% (95%CI: 84.9%-94.5%) vs. 89.5% (95%CI: 84.8%-94.3%)]; specificity [99.7% (95%CI: 99.2%-100.0%) vs. 100% (95%CI:100%-100%)]; positive predictive value (PPV) and negative predictive value (NPV) were 99.8% (95%CI:99.4%-100.0%) versus 100% (95%CI:100%-100%) and 85.3% (95%CI: 79.1%-91.5%) versus 85.1% (95%CI: 79.1%-1.0%), respectively; and Kappa [86.5% (95%CI:80.5%-92.5%) vs. 86.5% (95%CI:80.6%-92.3%)]. Performance measures were better among females than males; worst among the non-Hispanic white and best among other ra...Continue Reading

References

Jun 24, 1998·Chemical Research in Toxicology·S S Hecht
Jul 21, 1998·JAMA : the Journal of the American Medical Association·E J Pérez-StableN L Benowitz
May 25, 2002·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·UNKNOWN SRNT Subcommittee on Biochemical Verification
Oct 28, 2003·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Neal L BenowitzPeyton Jacob
Nov 25, 2003·Cancer·Lisa Sanderson CoxRichard D Hurt
Mar 1, 2005·Pharmacological Reviews·Janne HukkanenNeal L Benowitz
May 9, 2006·Clinical Pharmacology and Therapeutics·Neal L BenowitzPeyton Jacob
Jul 13, 2006·JAMA : the Journal of the American Medical Association·UNKNOWN International Early Lung Cancer Action Program InvestigatorsOlli S Miettinen
Oct 13, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jamie L StudtsRenato V LaRocca
Nov 7, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Chandra P BelaniMark A Socinski
Feb 28, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Sarah Connor GorberMark Tremblay
Dec 5, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Maciej L GoniewiczNeal L Benowitz
Mar 20, 2010·Journal of Exposure Science & Environmental Epidemiology·Amy E KalkbrennerBruce P Lanphear
Dec 1, 2010·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Yang XiaJames L Pirkle
Feb 19, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Maciej Lukasz GoniewiczNeal L Benowitz
Mar 25, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ralph S CaraballoLynn T Kozlowski
Aug 21, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Israel T AgakuGregory Connolly
Sep 24, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Israel T AgakuGregory N Connolly
Jan 11, 2014·Cancer Research·Jian-Min YuanStephen S Hecht
Dec 30, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Sungshim L ParkStephen S Hecht
Jan 8, 2015·Journal of Exposure Science & Environmental Epidemiology·Binnian WeiLanqing Wang
Jul 29, 2015·Environmental Health Perspectives·Katie M O'BrienClarice R Weinberg
Dec 19, 2015·Accounts of Chemical Research·Stephen S HechtSteven G Carmella
Mar 15, 2016·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Carlijn M van der Aalst, Harry J de Koning
May 14, 2016·The European Respiratory Journal·Jyoti MalhotraPaolo Boffetta
May 18, 2016·Pharmacology, Biochemistry, and Behavior·Kathryn C RossNeal L Benowitz
Jan 4, 2017·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Ram B Jain
Jan 18, 2017·Current Environmental Health Reports·Katie M O'BrienJessie P Buckley
Jun 5, 2017·The Medical Clinics of North America·Richard M Hoffman, Rolando Sanchez
Sep 13, 2018·American Journal of Public Health·Bruce S Pyenson, Samantha M Tomicki
Oct 2, 2019·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Neal L BenowitzMegan E Piper
May 7, 2020·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Bian LiuEmanuela Taioli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.